These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 22152406)

  • 1. A systems-based mathematical modelling framework for investigating the effect of drugs on solid tumours.
    Liu C; Krishnan J; Xu XY
    Theor Biol Med Model; 2011 Dec; 8():45. PubMed ID: 22152406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling the effects of cell-cycle heterogeneity on the response of a solid tumour to chemotherapy: biological insights from a hybrid multiscale cellular automaton model.
    Powathil GG; Gordon KE; Hill LA; Chaplain MA
    J Theor Biol; 2012 Sep; 308():1-19. PubMed ID: 22659352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards an integrated systems-based modelling framework for drug transport and its effect on tumour cells.
    Liu C; Krishnan ; Xu XY
    J Biol Eng; 2014; 8():3. PubMed ID: 24764492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A tumor cord model for doxorubicin delivery and dose optimization in solid tumors.
    Eikenberry S
    Theor Biol Med Model; 2009 Aug; 6():16. PubMed ID: 19664243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modular systems approach to understanding the interaction of adaptive and monostable and bistable threshold processes.
    Seaton D; Krishnan J
    IET Syst Biol; 2011 Mar; 5(2):81-94. PubMed ID: 21405196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bridging the gap between modules in isolation and as part of networks: A systems framework for elucidating interaction and regulation of signalling modules.
    Menon G; Krishnan J
    J Chem Phys; 2016 Jul; 145(3):035103. PubMed ID: 27448907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational modelling of drug delivery to solid tumour: Understanding the interplay between chemotherapeutics and biological system for optimised delivery systems.
    Zhan W; Alamer M; Xu XY
    Adv Drug Deliv Rev; 2018 Jul; 132():81-103. PubMed ID: 30059703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Conventional basis therapy of rheumatoid arthritis. Effects within and outside cells].
    Keyßer G
    Z Rheumatol; 2012 Aug; 71(6):468-72. PubMed ID: 22802023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An investigation of spatial signal transduction in cellular networks.
    Alam-Nazki A; Krishnan J
    BMC Syst Biol; 2012 Jul; 6():83. PubMed ID: 22765014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of tumour size on drug transport and uptake in 3-D tumour models reconstructed from magnetic resonance images.
    Zhan W; Gedroyc W; Xu XY
    PLoS One; 2017; 12(2):e0172276. PubMed ID: 28212385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive mathematical models of cancer signalling pathways.
    Bachmann J; Raue A; Schilling M; Becker V; Timmer J; Klingmüller U
    J Intern Med; 2012 Feb; 271(2):155-65. PubMed ID: 22142263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer: a Systems Biology disease.
    Hornberg JJ; Bruggeman FJ; Westerhoff HV; Lankelma J
    Biosystems; 2006; 83(2-3):81-90. PubMed ID: 16426740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigating the effects of ABC transporter-based acquired drug resistance mechanisms at the cellular and tissue scale.
    Liu C; Krishnan J; Xu XY
    Integr Biol (Camb); 2013 Mar; 5(3):555-68. PubMed ID: 23364280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mathematical modelling of drug transport and uptake in a realistic model of solid tumour.
    Zhan W; Gedroyc W; Xu XY
    Protein Pept Lett; 2014; 21(11):1146-56. PubMed ID: 25106906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer systems biology.
    Faratian D; Bown JL; Smith VA; Langdon SP; Harrison DJ
    Methods Mol Biol; 2010; 662():245-63. PubMed ID: 20824475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of cell adaptation: when and how do cancer cells develop chemoresistance?
    Fodale V; Pierobon M; Liotta L; Petricoin E
    Cancer J; 2011; 17(2):89-95. PubMed ID: 21427552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systems biology of cell behavior.
    Valeyev NV; Bates DG; Umezawa Y; Gizatullina AN; Kotov NV
    Methods Mol Biol; 2010; 662():79-95. PubMed ID: 20824467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of conventional chemotherapy, stealth liposomes and temperature-sensitive liposomes in a mathematical model.
    Gasselhuber A; Dreher MR; Rattay F; Wood BJ; Haemmerich D
    PLoS One; 2012; 7(10):e47453. PubMed ID: 23082168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systems biology approaches to enzyme kinetics: analyzing network models of drug metabolism.
    Finn NA; Kemp ML
    Methods Mol Biol; 2014; 1113():317-34. PubMed ID: 24523119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MetDFBA: incorporating time-resolved metabolomics measurements into dynamic flux balance analysis.
    Willemsen AM; Hendrickx DM; Hoefsloot HC; Hendriks MM; Wahl SA; Teusink B; Smilde AK; van Kampen AH
    Mol Biosyst; 2015 Jan; 11(1):137-45. PubMed ID: 25315283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.